June 20, 2011

In the year leading up to the switch of Allegra, Sanofi generated $214.2 million in U.S. prescription sales of Allegra, largely due to the generic competition against its Allegra D formulation. Now Sanofi is looking to virtually match those annual sales figures within the much more profitable nonprescription venue with the company’s successful switch from prescription to OTC this spring. 


May 23, 2011

The summer 2011 Allergy Relief Ingredient Guide breaks down the indication, active ingredients, purpose and dosage of such OTC allergy-symptom relievers as Claritin, Allegra, Zyrtec, Benadryl, Hyland's, Ocean, Similasan, Visine A.C. and Zaditor.

April 29, 2011

Sanofi-Aventis on Thursday reported strong sales out of the gate for its recently switched second-generation antihistamine Allegra.

April 25, 2011

Customers are seeing purple again — reminiscent of another switch that took advantage of the eye-catching color purple. Sanofi-Aventis through its Chattem division in March launched Allegra, the last of the second-generation antihistamines. And purple-powered displays, like this in a Walmart in Lancaster, Pa., dotted the retail pharmacy landscape.


April 14, 2011

The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.

March 7, 2011

An over-the-counter version of the antihistamine Allegra hit the marketplace amid a promotional frenzy that was consistent with the approach taken when such similar products as Claritin and Zyrtec became available without a prescription. As was the case with other products before it, retailers are eager to get their share of sales, so there tends to be considerable activity around the launch.

February 18, 2011

PARIS — Allegra is less than a week away from reaching shelves on March 4, and with the latest allergy switch will come a significant number of Rx allergy sufferers this summer.


February 18, 2011

All the hype around H1N1 
that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later.

February 1, 2011

A federal court has lifted an injunction that had prevented drug maker Dr. Reddy’s Labs from marketing a generic version of an allergy drug.

January 28, 2011

Though Schering-Plough’s — now Merck’s — Claritin and Johnson & Johnson’s Zyrtec product lines have dominated the over-the-counter antihistamine market, the big share of the prescription antihistamine market held by Sanofi-Aventis’ Allegra (fexofenadine hydrochloride) could give it a battering ram to bust in as well, thanks to the big break Sanofi got in the form of a Food and Drug Administration approval of an OTC switch for the drug.

January 25, 2011

Sanofi-Aventis and its U.S. consumer healthcare division Chattem on Tuesday afternoon announced the Food and Drug Administration has approved the Allegra (fexofenadine HCl) family of allergy medication products for over-the-counter use in adults and children 2 years of age and older.

November 15, 2010

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

June 28, 2010

Perrigo on Tuesday announced that it has acquired the exclusive U.S. store brand rights to...

June 14, 2010

A U.S. District Court has granted French drug maker Sanofi-Aventis and Albany Molecular Research an...

June 6, 2010

Switch always has been the most significant driver of revenues within the non-prescription aisles, with...

May 16, 2010

As of Feb. 9, Sanofi-Aventis officially entered the self-care solution arena with its acquisition of...

January 10, 2010

Sanofi-Aventis is the latest pharma powerhouse to make the move toward over-the-counter medicine with its...

December 20, 2009

This is further substantiation that the business of over-the-counter medicines, particularly those sold in the...